Skip to main content

"Vi har registreret, at du besøger siden fra {0}. Vil du skifte sprog for at se indhold, der er tilpasset dig?"

->

3M Prevena Therapy for cardiothoracic surgery

Advancing the standard of care in cardiothoracic surgery

Cardiothoracic surgery patient care extends beyond the operating room (OR). While confidence in the OR is essential, postoperative concerns like infections, swelling and tissue integration can impact recovery. 3M™ Prevena™ Therapy provides you with a proactive strategy for incision care, elevating the standard of postoperative treatment and optimising the healing environment to enhance your patients' recovery experience.

Sternum snit med 3M™ Prevena™ Peel and Place System Kit påført. MedPeople_OR_11045
Impact of Prevena Therapy Proactive Risk Management Videos Resources
På denne side...
Impact of Prevena Therapy
Proactive Risk Management
Videos
Resources

Enhanced cardiothoracic surgery outcomes with Prevena Therapy

A peer-reviewed meta-analysis of 7 studies for cardiac surgical procedures demonstrated Prevena Therapy helped significantly reduce the risk of surgical site infections (SSIs) compared to standard-of-care dressings.¹

Icon illustration 49.3%
Reduction in SSIs1,*

7 studies; p<0.001† 

Icon illustration 61% with down arrow
Reduction in risk of SSIs in high risk patients1,* 

2 studies; p=0.004† 

*Relative risk reduction.

†Calculation(s) are derived based on the relative patient group incidence rate reporting in this study. Statistically significant (p<0.05).

See full indications for use and limitations at hcbgregulatory.3M.com.

Prevena Therapy video resources

Kontakt en Solventum-repræsentant

Vi er her for at hjælpe! Vores team af repræsentanter kan give dig information og ressourcer til at hjælpe dig. Indsend formularen nedenfor for at tale med en Solventum-repræsentant for at lære mere om dine muligheder.

Leder du efter kundesupport? Besøg siden med kundesupport.

Felter markeret med * er obligatoriske.

Venligst indtast en arbejds-e-mailadresse

 

Solventum vil bruge oplysningerne til at svare på din anmodning og i overensstemmelse med vores politik om beskyttelse af personlige oplysninger.

Vi beklager. Der opstod en fejl under indsendelsen. Prøv igen senere

There was an error processing your request. Please try again later.

Kontakt en Solventum-repræsentant

Vi er her for at hjælpe! Vores team af repræsentanter kan give dig information og ressourcer til at hjælpe dig. Indsend formularen nedenfor for at tale med en Solventum-repræsentant for at lære mere om dine muligheder.

Leder du efter kundesupport? Besøg siden med kundesupport.

Felter markeret med * er obligatoriske.

Venligst indtast en arbejds-e-mailadresse

 

Solventum vil bruge oplysningerne til at svare på din anmodning og i overensstemmelse med vores politik om beskyttelse af personlige oplysninger.

Vi beklager. Der opstod en fejl under indsendelsen. Prøv igen senere

There was an error processing your request. Please try again later.

NOTE:

Specific indications, limitations, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. This material is intended for healthcare professionals.

Indication(s) For Use / Intended Use:

The 3M™ Prevena™ Plus 125 Therapy Unit, when used with 3M™ Prevena™ Dressings (3M™ Prevena™ Plus Incision Management System), is intended to manage the environment of closed surgical incisions and surrounding intact skin in patients at risk for developing post-operative complications, such as infection, by maintaining a closed environment via the application of a negative pressure wound therapy system to the incision.

See full indications and limitations for use at hcbgregulatory.3m.com

Referencer:

  1. Loubani M, Cooper M, Silverman R, Bongards C, Griffin L. Surgical site infection outcomes of two different closed incision negative pressure therapy systems in cardiac surgery: Systematic review and meta-analysis. Int Wound J. 2024;21(1):e14599. doi:10.1111/iwj.14599
  2. Berríos-Torres, S. I., Umscheid, C. A., Bratzler, D. W., Leas, B., Stone, E. C., Kelz, R. R., Reinke, C. E., Morgan, S., Solomkin, J. S., Mazuski, J. E., Dellinger, E. P., Itani, K. M., Berbari, E. F., Segreti, J., Parvizi, J., Blanchard, J., Allen, G., Kluytmans, J. A., Donlan, R., & Schecter, W. P. (2017). Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surgery, 152(8), 784. https://doi.org/10.1001/jamasurg.2017.0904
  3. Ban, K. A., Minei, J. P., Laronga, C., Harbrecht, B. G., Jensen, E. H., Fry, D. E., Itani, K. M. F., Dellinger, P. E., Ko, C. Y., & Duane, T. M. (2017). American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 update. Journal of the American College of Surgeons, 224(1), 59–74. https://doi.org/10.1016/j.jamcollsurg.2016.10.029